Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gadrovit 9G
- Development stage
- Unknown
- Lead developer
- Avogadro Lifesciences
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Gadrovit 9G is a multi-ingredient dietary supplement marketed by Avogadro, primarily within the Indian pharmaceutical and nutraceutical market. It is formulated as a combination of nine distinct herbal extracts (the "9G" components), essential vitamins, minerals, and often omega-3 fatty acids. The "9G" typically refers to a standardized blend of Ginseng, Ginkgo Biloba, Green Tea Extract, Grape Seed Extract, Garlic, Guggul, Ginger, Green Coffee Bean, and Glycyrrhiza glabra. This product is designed to serve as a potent antioxidant and nutritional support system, aimed at enhancing energy levels, supporting cognitive and cardiovascular health, and boosting the immune system by protecting cells from oxidative stress and replenishing micronutrient deficiencies.
- Brand names
- Gadrovit 9GGadrovit9GGadrovit-9G
- Other names
- Gadrovit 9G CapsulesGadrovit9G CapsulesGadrovit-9G Capsules
Beyond the preview
Go deeper on Gadrovit 9G.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gadrovit 9G.